Tecentriq

408,260

Product Type Product Size
Injection 1’S
Product Company
Roche Pharma

Atezolizumab 1200mg/20ml

Category:

Description


Atezolizumab, sold under the brand name Tecentriq, is a monoclonal antibody medication used to treat urothelial carcinoma, non-small cell lung cancer, triple-negative breast cancer, small cell lung cancer, hepatocellular carcinoma, and alveolar soft part sarcoma.

Reviews

There are no reviews yet.

Be the first to review “Tecentriq”

Your email address will not be published. Required fields are marked *

Quick Comparison

SettingsTecentriq removeLetrasan removeTrastuget removeTuximab removeSoranix removeTrexol remove
NameTecentriq removeLetrasan removeTrastuget removeTuximab removeSoranix removeTrexol remove
Image
SKU
Rating
Price408,2607,609101,60449,46088,01016,710255
Stock
Availability
Add to cart

Description
Product Type Product Size
Injection 1'S
Product Company
Roche Pharma
Atezolizumab 1200mg/20ml
Product Type Product Size
Tablet 30'S
Product Company
Manufacture Deva Holding / Marketed by Searle
Letrozole 2.5mg
Product Type Product Size
Injection 1'S
Product Company
Getz Pharma
Trastuzumab 440mg/10ml
Product Type Product Size Product Company
Injection 1'S Roche Pharma
Product Type Product Size
Tablets 30'S
Product Company
Beacon Pharmaceuticals
Sorafenib 200mg
Product Type Product Size
Injection 1'S
Product Company
Helix pharma
Methotrexate 50mg/2ml
Content" Atezolizumab, sold under the brand name Tecentriq, is a monoclonal antibody medication used to treat urothelial carcinoma, non-small cell lung cancer, triple-negative breast cancer, small cell lung cancer, hepatocellular carcinoma, and alveolar soft part sarcoma.Letrozole is a non-steroidal type II aromatase inhibitor. It blocks the active site, and therefore the electron transfer chain of CYP19A1. This competitive inhibition prevents the conversion of androgens to estrogen. This action leads to a reduction in uterine weight and elevated leuteinizing hormon.Trastuzumab is a monoclonal anti-human epidermal growth factor receptor 2 protein antibody used to treat HER2-positive breast, gastroesophageal, and gastric cancers." Rituximab is a biological therapy used for rheumatoid arthritis, lupus, vasculitis and dermatomyositisSorafenib is used to treat late-stage kidney cancer (advanced renal cell carcinoma), liver cancer (hepatocellular carcinoma) that cannot be treated by surgery, and differentiated thyroid cancer that has come back or spread to other parts of your body. Sorafenib is an antineoplastic (cancer) agent. Methotrexate is an antineoplastic agent used the treatment of a wide variety of cancers as well as severe psoriasis, severe rheumatoid arthritis, and juvenile rheumatoid arthritis.
WeightN/AN/AN/AN/AN/AN/A
DimensionsN/AN/AN/AN/AN/AN/A
Additional information
Dose

100mg/10ml, 500mg/50ml